Juvenile Idiopathic arthritis and infectious arthritis 郭三元 Division of R-I-A TSGH
Juvenile rheumatoid arthritis Juvenile chronic arthritis Juvenile Idiopathic arthritis
Polyarticular type (20-30%) Oligoarticular type (50-60%) Systematic types (10%) Enthesitis-related arthritis Psoriatic arthritis 5 joints or more 4 joints or less
Juvenile idiopathic arthritis Prevalence:12-113/100000, incidence 9- 25/ Age of onset < 16 years Disease duration > 6 weeks In oilgo- and poly- type: female > male, in systemic type: male=female ESR usually elevated in poly- and systemic type, normal in oligo- type
Lab test CBC, ESR, CRP RF ANA HLA-B27 Ferritin Anti-ccp
Genetic susceptibility Spondyloarthropathy---HLA-B27 RF+ polyarticular – HLA-DR1 and HLA- DR4 Early onset of oligoarticular with chronic uveitis ---HLA-DR5 and HLA-DR8 Early onset oligoarticular --- HLA DQW1 and DPW2 Systemic type--- HLA-DR4
Polyarticular type Symmetrical, large and small joints Peak age of onset: 1-3 years F:M: 3 : 1 Chronic uveitis: 5% ANA: 40-50% Positive RF –10%, increased risk of joint damage, more aggressive arthritis
Oligoarticular type Peak age of onset: 2-5 years F:M 5 : 1 High frequency of positive ANA (70-80%) Chronic uveitis- related to positive ANA RF: rare Old age of onset (> 6 year), more often in males, with often HLA-B27 positive
Localized inflammation and cytokine release Increase blood flow -- macroepiphysis Longer affected leg
Evanescent skin rash (salmon-pink) High fever Polyarthragia/arthritis F:M:1:1 RF: rare ANA: <10% Uveitis: rare hepatosplenomegaly, lymphadenopathy, pericarditis high ferritin Systemic type (Still’s disease)
Koebner phenomenon
Management Minimize the joint damage, early diagnosis and early treatment Keep muscle strong and limb in good position, keep joint moving Physical therapy and exercise Routine eye examination from 3-4 months interval to one year
Management NSAIDs Steroid DMARDs Biological agents ( anti-TNFα, anti-IL6)
Prognosis Oligoarticular type: 80% resolved after 15 years, 15% develop polyarticular type with severe joints problems, 50% decreased visual acuity after 10 years ( uveitis ) and 25% developed cataract or glaucoma Polyarticular type: RF(+) showed more severe course and only 33% became independent after 15 years Systemic type : 50% remission, others developed severe arthritis and especially in cases of disease onset < 5 years-old
Growing pain Age attacked: 4-12 years F: M: 1:1 Deep aching, cramping pain in thigh or calf Usually in evening or during the night, never in the morning Normal physical examination and laboratory
Infection related arthritis
Septic arthritis Acute onset of monoarthritis Fever Elevated ESR or CRP Synovial fluid: WBC> 50000
Incidence of septic arthritis 2-5 /100,000/year in general population /100,000/year in children 28-38/100,000/year in RA patients 40-68/100,000/year in prosthetic joint
Pathogenesis Hematogenous route from a kind of remote infectious disease (70% ) – abundant vascular supply of synovium and lack of limiting basement membrane dissemination from near osteomyelitis Lymphatic spread from infection near the joint Iatrogenic infections from arthrocentesis or arthroscope (20% ) Penetrating trauma from plant thorns or other contaminated objects
Predisposing factors Impaired host defense Direct penetration Joint damage Host phagocytic defect
Impaired host defense Neoplastic disease Elderly (>65 years) Children (<5 years) Chronic illness ( DM, cirrhosis, chronic renal disease, HIV) Immunosuppressive agents
Direct penetration Intravenous drug abuse Puncture wounds Invasive procedures
Joint damage Prosthetic joints RA Hemarthrosis OA
Host phagocytic defects Complement deficiency Impaired chemotaxis
Relate to joint Knee Hip Ankle Shoulder Wrist Elbow Bursa
Radiological features Joint effusion Erosion Joint space narrowing Joint deformity Osteoporosis Bony ankylosis
Indication for surgical drainage Hip and shoulder joint, S-C joint Vertebral osteomyelitis with cord compression Thick synovial purulent fluid or loculated Persistent positive synovial fluid culture Prosthetic joints Associated with osteomyelitis Delayed onset of therapy (>1 week)